UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 810

Sortiert nach

Overview of the Actions of Glucocorticoids on the Immune Response: A Good Model to Characterize New Pathways of Immunosuppression for New Treatment Strategies

Annals of the New York Academy of Sciences, 2004-06, Vol.1024 (1), p.124-137

FRANCHIMONT, D

2004

Link zum Volltext

Verfügbarkeit prüfen

Predicting relapse in Crohn’s disease: a biopsychosocial model

Gut, 2008-10, Vol.57 (10), p.1386-1392

2008

Link zum Volltext

Verfügbarkeit prüfen

Short course chemotherapy followed by concomitant chemoradiotherapy and surgery in locally advanced rectal cancer: a randomized multicentric phase II study

Annals of oncology, 2012-06, Vol.23 (6), p.1525-1530

2012

Link zum Volltext

Verfügbarkeit prüfen

Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn’s disease and ulcerative colitis

Gut, 2004-07, Vol.53 (7), p.987-992

2004

Link zum Volltext

Verfügbarkeit prüfen

Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naïve patients with ulcerative colitis

Journal of Crohn's and colitis, 2012-06, Vol.6 (5), p.557-562

2012

Link zum Volltext

Verfügbarkeit prüfen

An insertion–deletion polymorphism in the Interferon Regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseases

Human molecular genetics, 2007-12, Vol.16 (24), p.3008-3016

2007

Link zum Volltext

Verfügbarkeit prüfen

The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases

Genes and immunity, 2007-07, Vol.8 (5), p.387-397

2007

Link zum Volltext

Verfügbarkeit prüfen

Le dépistage organisé du cancer colorectal en Communauté française de Belgique et surveillance des polypes

Revue médicale de Bruxelles, 2009, Vol.30 (4), p.253-260

2009

Link zum Volltext

Verfügbarkeit prüfen

Incidence and Predictors of Success of Adalimumab Dose Escalation and De-escalation in Ulcerative Colitis: a Real-World Belgian Cohort Study

Inflammatory bowel diseases, 2018-04, Vol.24 (5), p.1099-1105

2018

Link zum Volltext

Verfügbarkeit prüfen

Rapid improvement of bone metabolism after infliximab treatment in Crohn's disease

Alimentary pharmacology & therapeutics, 2004-09, Vol.20 (6), p.607-614

2004

Link zum Volltext

Verfügbarkeit prüfen

Belgian IBD research group (BIRD) position statement 2017 on the use of biosimilars in inflammatory bowel diseases (IBD)

Acta gastro-enterologica belgica, 2018-01, Vol.81 (1), p.49-53

2018

Link zum Volltext

Verfügbarkeit prüfen

Tumour necrosis factor (TNF) gene polymorphism influences TNF‐α production in lipopolysaccharide (LPS)‐stimulated whole blood cell culture in healthy humans

Clinical and experimental immunology, 1998-09, Vol.113 (3), p.401-406

1998

Link zum Volltext

Verfügbarkeit prüfen

Gastric endometriosis associated with transverse colon endometriosis: a case report of a very rare event

Archives of gynecology and obstetrics, 2014-12, Vol.290 (6), p.1275-1277

2014

Link zum Volltext

Verfügbarkeit prüfen

O054 TM6SF2-T and PNPLA3-G genetic variants co-modulate the risk of hepatocellular carcinoma in caucasian patients with alcoholic cirrhosis. Inter-cohort validation in 1068 patients

Journal of hepatology, 2015-04, Vol.62, p.S218-S219

2015

Link zum Volltext

Verfügbarkeit prüfen

L-carnitine, a diet component and organic cation transporter OCTN ligand, displays immunosuppressive properties and abrogates intestinal inflammation

Clinical and experimental immunology, 2009-04, Vol.156 (1), p.161-171

2009

Link zum Volltext

Verfügbarkeit prüfen

25 ans de l’association polypose adénomate familiale belge : résultats et enseignements d’un registre national

Journal de chirurgie viscérale, 2019-05, Vol.156, p.e17-e18

2019

Link zum Volltext

Verfügbarkeit prüfen

Increased production of matrix metalloproteinase‐3 and tissue inhibitor of metalloproteinase‐1 by inflamed mucosa in inflammatory bowel disease

Clinical and experimental immunology, 2000-05, Vol.120 (2), p.241-246

2000

Link zum Volltext

Verfügbarkeit prüfen

inhibitor of interleukin-6 trans-signalling, sgp130, contributes to impaired acute phase response in human chronic liver disease

Clinical and experimental immunology, 2009-06, Vol.156 (3), p.518-527

2009

Link zum Volltext

Verfügbarkeit prüfen

P418 Lipopolysaccharide-Binding Protein (LBP) in Crohn's Disease (CD) Patients: A Promising Non-Invasive Biomarker Monitoring Disease Activity

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i862-i864

2024

Link zum Volltext

Verfügbarkeit prüfen

Profile of soluble cytokine receptors in Crohn’s disease

Gut, 2005-04, Vol.54 (4), p.488-495

2005

Link zum Volltext

Verfügbarkeit prüfen

120 SEVERE VITAMIN D DEFICIENCY IS ASSOCIATED WITH COMPLICATIONS OF PORTAL HYPERTENSION AND A WORSE PROGNOSIS IN ALCOHOLIC CIRRHOSIS

Journal of hepatology, 2013-04, Vol.58, p.S54-S54

2013

Link zum Volltext

Verfügbarkeit prüfen

LO6 : A two-stage genome-wide association study identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis

Journal of hepatology, 2015-04, Vol.62, p.S260-S261

2015

Link zum Volltext

Verfügbarkeit prüfen

The Tnf/Adam 17 System: Implication of an Adam 17 Haplotype in the Clinical Response to Infliximab in Crohn's Disease

Pharmacogenetics and genomics, 2006-10, Vol.16 (10), p.727-734

2006

Link zum Volltext

Verfügbarkeit prüfen

No association between C-reactive protein gene polymorphisms and decrease of C-reactive protein serum concentration after infliximab treatment in Crohnʼs disease

Pharmacogenetics and genomics, 2006-01, Vol.16 (1), p.37-42

2006

Link zum Volltext

Verfügbarkeit prüfen

Clinical pattern of corticosteroid dependent Crohnʼs disease

European journal of gastroenterology & hepatology, 1998-10, Vol.10 (10), p.821-826

1998

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 810

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(599)
Mit Volltextzugriff
(280)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(512)
Female
(235)
Male
(202)
Science & Technology
(161)
Life Sciences & Biomedicine
(159)
Adult
(153)
Human Health Sciences
(117)
Sciences De La Santé Humaine
(117)
Middle Aged
(106)
Biological And Medical Sciences
(97)
Medical Sciences
(80)
Animals
(72)
Aged
(55)
Gastroenterology & Hepatology
(46)
Adolescent
(43)
Radioimmunoassay
(42)
Sciences Biologiques Et Medicales
(41)
Diagnosis, Differential
(36)
General & Internal Medicine
(36)
Follicle Stimulating Hormone - Blood
(34)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Overview of the Actions of Glucocorticoids on the Immune Response: A Good Model to Characterize New Pathways of Immunosuppression for New Treatment Strategies

Predicting relapse in Crohn’s disease: a biopsychosocial model

Short course chemotherapy followed by concomitant chemoradiotherapy and surgery in locally advanced rectal cancer: a randomized multicentric phase II study

Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn’s disease and ulcerative colitis

Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naïve patients with ulcerative colitis

An insertion–deletion polymorphism in the Interferon Regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseases

The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases

Le dépistage organisé du cancer colorectal en Communauté française de Belgique et surveillance des polypes

Incidence and Predictors of Success of Adalimumab Dose Escalation and De-escalation in Ulcerative Colitis: a Real-World Belgian Cohort Study

Rapid improvement of bone metabolism after infliximab treatment in Crohn's disease

Belgian IBD research group (BIRD) position statement 2017 on the use of biosimilars in inflammatory bowel diseases (IBD)

Tumour necrosis factor (TNF) gene polymorphism influences TNF‐α production in lipopolysaccharide (LPS)‐stimulated whole blood cell culture in healthy humans

Gastric endometriosis associated with transverse colon endometriosis: a case report of a very rare event

O054 TM6SF2-T and PNPLA3-G genetic variants co-modulate the risk of hepatocellular carcinoma in caucasian patients with alcoholic cirrhosis. Inter-cohort validation in 1068 patients

L-carnitine, a diet component and organic cation transporter OCTN ligand, displays immunosuppressive properties and abrogates intestinal inflammation

25 ans de l’association polypose adénomate familiale belge : résultats et enseignements d’un registre national

Increased production of matrix metalloproteinase‐3 and tissue inhibitor of metalloproteinase‐1 by inflamed mucosa in inflammatory bowel disease

inhibitor of interleukin-6 trans-signalling, sgp130, contributes to impaired acute phase response in human chronic liver disease

P418 Lipopolysaccharide-Binding Protein (LBP) in Crohn's Disease (CD) Patients: A Promising Non-Invasive Biomarker Monitoring Disease Activity

Profile of soluble cytokine receptors in Crohn’s disease

120 SEVERE VITAMIN D DEFICIENCY IS ASSOCIATED WITH COMPLICATIONS OF PORTAL HYPERTENSION AND A WORSE PROGNOSIS IN ALCOHOLIC CIRRHOSIS

LO6 : A two-stage genome-wide association study identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis

The Tnf/Adam 17 System: Implication of an Adam 17 Haplotype in the Clinical Response to Infliximab in Crohn's Disease

No association between C-reactive protein gene polymorphisms and decrease of C-reactive protein serum concentration after infliximab treatment in Crohnʼs disease

Clinical pattern of corticosteroid dependent Crohnʼs disease

Suchergebnisse filtern